Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
33.30
0.00 (0.00%)
At close: Oct 6, 2025
BIOVF Market Cap
BIOVF has a market cap or net worth of $10.92 billion as of October 10, 2025. Its market cap has decreased by -0.35% in one year.
Market Cap
10.92B
Enterprise Value
12.16B
Revenue
2.84B
Ranking
n/a
PE Ratio
23.75
Stock Price
$33.30
Market Cap Chart
Since September 15, 2006, BIOVF's market cap has increased from 663.04M to 10.92B, an increase of 1,546.76%. That is a compound annual growth rate of 15.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 11.06B | 10.83% |
| Dec 30, 2024 | 9.98B | 9.75% |
| Dec 29, 2023 | 9.09B | 46.56% |
| Dec 30, 2022 | 6.20B | 1.41% |
| Dec 30, 2021 | 6.12B | 2.35% |
| Dec 30, 2020 | 5.98B | 22.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 683.67M |
| Glass House Brands | 645.74M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 274.14M |
| Silence Therapeutics | 242.78M |